Liraglutide Plus Megestrol Acetate in Endometrial Atypical Hyperplasia

Clinical trial NCT04683237 · WITHDRAWN

Trial details

NCT number: NCT04683237
Sponsor: Xiaojun Chen
Status: WITHDRAWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Atypical Endometrial Hyperplasia Obese Fertility Issues

Start date: 2021-03-20
Primary completion: 2025-11-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.